Park Place Capital’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Park Place Capital's DYN Position: Q2 2026 in Review
Park Place Capital sold out of Dyne Therapeutics (DYN) in Q2 2026, closing a stake of 47 shares — an estimated $852 sold.
Park Place Capital first reported a position in DYN in Q1 2026 and held it in 1 quarter. The position peaked at $852 in Q1 2026. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.
- Park Place Capital reported no remaining Dyne Therapeutics position as of Q2 2026 after selling out during the quarter.
- Park Place Capital sold 47 Dyne Therapeutics shares in Q2 2026, an estimated $852.
- Park Place Capital first reported a position in Dyne Therapeutics in Q1 2026 and held it in 1 quarter.
- Park Place Capital's Dyne Therapeutics position peaked at $852 in Q1 2026.
- 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.
Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.